Polyglutamine expansion neurodegenerative disease.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Brain Research Bulletin

• Publication date

  2001-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0361-9230(01)00577-9PMID 11719245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice.

  2001cited by this paper
• Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

  2000cited by this paper
• The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

  2000cited by this paper
• Identification of genes that modify ataxin-1-induced neurodegeneration

  2000cited by this paper
• Genetic suppression of polyglutamine toxicity in Drosophila.

  2000cited by this paper
• CREB-binding protein sequestration by expanded polyglutamine.

  2000cited by this paper
• Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

  1998cited by this paper
• Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy.

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

  1998cited by this paper
• Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

  1997cited by this paper
• Trinucleotide repeats in neurogenetic disorders.

  1996cited by this paper
• SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

  1995cited by this paper
• Meiotic stability and genotype – phenotype correlation of the trinucleotide repeat in X–linked spinal and bulbar muscular atrophy

  1992cited by this paper
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

  1991cited by this paper
• X-linked recessive bulbospinal neuronopathy. A clinicopathological study.

  1989cited by this paper
• Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.

  1968cited by this paper

• Sex and sex hormone differences in hippocampal neurogenesis and their relevance to Alzheimer’s disease

  2021cites this paper
• The Nt17 domain and its helical conformation regulate the aggregation, cellular properties and neurotoxicity of mutant huntingtin exon 1

  2021cites this paper
• Towards deciphering the Nt17 code: How the sequence and conformation of the first 17 amino acids in Huntingtin regulate the aggregation, cellular properties and neurotoxicity of mutant Httex1

  2021cites this paper
• THE PHYSIOPATHOLOGICAL ROLES OF ANDROGENS IN MOTONEURONS

  2020cites this paper
• Developing an antisense oligonucleotide treatment for Spinocerebellar Ataxia Type 3

  2018cites this paper
• Spinal and Bulbar Muscular Atrophy (Kennedy Disease)

  2017cites this paper
• Current targeted therapeutic strategies for oculopharyngeal muscular dystrophy: from pharmacological to RNA replacement and gene editing therapies

  2016cites this paper
• Antisense oligonucleotides in therapy for neurodegenerative disorders.

  2015cites this paper
• Therapeutic Strategies for Huntington's Disease.

  2015cites this paper
• Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy

  2014cites this paper
• Foundation-directed therapeutic development in Huntington's disease.

  2014cites this paper
• Fundamentals of Protein Folding

  2014influential citation
• Huntington’s Disease: Molecular Pathogenesis and New Therapeutic Perspectives

  2014cites this paper
• Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.

  2013cites this paper
• A decade and a half of protein intrinsic disorder: Biology still waits for physics

  2013cites this paper
• Factors Affecting Aggregate Formation in Cell Models of Huntington’s Disease and Amyotrophic Lateral Sclerosis

  2013cites this paper
• Enhanced Aggregation of Androgen Receptor in Induced Pluripotent Stem Cell-derived Neurons from Spinal and Bulbar Muscular Atrophy*

  2013cites this paper
• Changes of Pituitary Gland Volume in Kennedy Disease

  2013cites this paper
• Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease.

  2012cites this paper
• Why are we Interested in the Unfolded Peptides and Proteins

  2012cites this paper
• Alteration of protein folding and degradation in motor neuron diseases: Implications and protective functions of small heat shock proteins.

  2012cites this paper
• RNAi-based therapies for Huntington's disease: delivery challenges and opportunities.

  2012cites this paper
• Polymorphism of CAG repeats in androgen receptor of carnivores

  2012cites this paper
• Aggregation of PolyQ Proteins Is Increased upon Yeast Aging and Affected by Sir2 and Hsf1: Novel Quantitative Biochemical and Microscopic Assays

  2012cites this paper
• Editorial

  2011cites this paper
• Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.

  2011cites this paper
• Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.

  2011cites this paper
• Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy.

  2011cites this paper
• Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington’s disease mice

  2011cites this paper
• Histone deacetylation and motor neuron degeneration.

  2010cites this paper
• Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy.

  2010cites this paper
• Understanding protein non-folding.

  2010cites this paper
• Mendelian genetics of male infertility

  2010cites this paper
• Small Ubiquitin-like Modifier (SUMO) Modification of the Androgen Receptor Attenuates Polyglutamine-mediated Aggregation*♦

  2009cites this paper
• Natural history of spinal-bulbar muscular atrophy

  2008cites this paper
• Tandem repeats in human disorders: mechanisms and evolution.

  2008cites this paper
• The role of the polyglutamine tract in androgen receptor.

  2008cites this paper
• Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer theories.

  2007cites this paper
• Autosomálně dominantní spinocerebelární ataxie

  2007cites this paper
• Identification and Characterization of Phenotypically Distinct Aggregates within Huntingtin-inducible PC12 Cell Models

  2007cites this paper
• Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.

  2007cites this paper
• Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy.

  2007cites this paper
• Mechanisms of disease II: cellular protein quality control.

  2007cites this paper
• Introduction to Human Molecular Genetics

  2005cites this paper
• Androgen‐induced neurite outgrowth is mediated by neuritin in motor neurones

  2005cites this paper
• [A clinical, neurophysiological and molecular study of 12 patients from 4 families with spinal and bulbar muscular atrophy].

  2005cites this paper
• Reflections on the diseases linked to mutations of the androgen receptor

  2005cites this paper
• L’amyotrophie bulbaire et spinale liée au chromosome X : une étude clinique, neurophysiologique et moléculaire de 12 patients issus de 4 familles

  2005cites this paper
• CHAPTER D2 – Transgenic Rodent Models of Huntington Disease

  2005cites this paper
• Post mortem sampling of the brain and other tissues in neurodegenerative disease

  2004cites this paper
• [Molecular physiopathology of the spinocerebellar ataxia type 6 (SCA6)].

  2004cites this paper
• The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons.

  2004cites this paper
• Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders.

  2004cites this paper
• Kennedy's disease: pathogenesis and clinical approaches

  2004cites this paper
• Spinocerebellar ataxia type 17 in the Yugoslav population

  2004cites this paper
• Yeast as a model organism to study diseases of protein misfolding

  2004cites this paper
• Cell cycle regulation of neuronal apoptosis in development and disease.

  2004cites this paper
• Cells exposed to a huntingtin fragment containing an expanded polyglutamine tract show no sign of ion channel formation: Results arguing against the ion channel hypothesis

  2003cites this paper
• [Cerebellar cortical abiotrophy in American Staffordshire terriers: clinical and pathological description of 3 cases].

  2003cites this paper
• Neurological diseases and RNA-directed gene regulation: prospects for new diagnostics and therapy

  2003cites this paper
• Guidelines for the pathoanatomical examination of the lower brain stem in ingestive and swallowing disorders and its application to a dysphagic spinocerebellar ataxia type 3 patient

  2003cites this paper
• Identifying new therapeutics for Huntington's disease

  2003cites this paper
• Zerebelläre kortikale Abiotrophie beim American Staffordshire Terrier: Klinische und pathologische Beschreibung von drei Fällen.

  2003cites this paper
• The nucleus raphe interpositus in spinocerebellar ataxia type 3 (Machado-Joseph disease).

  2003cites this paper
• Chapter 4 Neuroimaging in Motor Neuron Disorders

  2003cites this paper
• Androgen 5‐Alpha‐Reductase Type 2 is Highly Expressed and Active in Rat Spinal Cord Motor Neurones

  2003cites this paper
• Polyglutamine diseases: a transcription disorder?

  2003cites this paper
• Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.

  2003cites this paper
• Clinical and molecular contributions to the understanding of X-linked mental retardation

  2003cites this paper
• Kennedy's Disease Initially Manifesting as an Endocrine Disorder.

  2003influential citation
• Enhanced SUMOylation in polyglutamine diseases.

  2002cites this paper
• Gene Regulation in Neuronal Degeneration - Role of mSin3 and YY1 factors

  2002cites this paper
• Mouse models for neurological disease.

  2002cites this paper
• Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.

  2002cites this paper
• Dominantly inherited, non-coding microsatellite expansion disorders.

  2002cites this paper
• Polyglutamine fibrillogenesis: The pathway unfolds

  2002cites this paper
• Transglutaminase‐mediated crosslinking of neural proteins in Alzheimer's disease and other primary dementias

  2002cites this paper
• Evaluation of FOXP2 as an autism susceptibility gene.

  2002cites this paper
• Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motoneuronal processes

  2002cites this paper
• PQBP-1 increases vulnerability to low potassium stress and represses transcription in primary cerebellar neurons.

  2002cites this paper